Table 2.
Results of stepwise haplotype association analysis
SNPs | ΔLRT | P | ||||
---|---|---|---|---|---|---|
rs2274700 | 135.42 | <0.0001 | ||||
rs2274700 | rs1280514 | 53.27 | <0.0001 | |||
rs2274700 | rs1280514 | rs412852 | 30.66 | <0.0001 | ||
rs2274700 | rs1280514 | rs412852 | rs11582939 | 96.81 | <0.0001 | |
rs2274700 | rs1280514 | rs412852 | rs11582939 | rs1048663 | 19.22 | 0.0104 |
Empirical P value was adjusted for multiple testing and was assessed using 10,000 permutations. A permutated sample was obtained by permuting disease affection status among affected individuals and controls while preserving evidence for association among SNPs selected in the previous step. Specifically, at each step, we grouped individuals according to genotype patterns at previously selected SNPs, and then permuted the disease affection status within each group of individuals with the same genotype pattern. Haplotype association was evaluated using a likelihood ratio test to compare haplotype frequencies between cases and controls. The likelihood ratio statistic was calculated with FUGUE-CC28. ΔLRT, difference in the likelihood ratio statistic between the current step and the previous step.